European Pharmaceutical Review

JANUARY 31, 2025

By the end of the decade, two cell and gene therapies will be subject to follow-on competition for the first time, beginning a whole new chapter in the biosimilar history. Over time, patient volumes (patient treatment days) and levels of competition, including market share, were also considered. 6 billion in 2024 alone).

Medicine 52

Medicine Competition Marketing Patients 52

Healthcare Success

JULY 5, 2022

(Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Every time I run into someone who is faced with the daunting challenge of marketing to doctors or other healthcare professionals, I giggle empathetically and say, “I feel your pain.”. Conclusion.

Doctors 55

Doctors Physicians Marketing Healthcare 55

Healthcare Success

APRIL 20, 2023

At Healthcare Success, we have been sharing marketing knowledge, tips, and tricks since our agency’s founding in 2006. Start With Some Classics Whether you’re a new marketer or a seasoned professional, take a deep dive into essential topics that can significantly impact your healthcare business.

Healthcare 52

Healthcare Healthcare Marketing Media 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64

Pharma Medicine Competition Marketing 64

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

CloserIQ

OCTOBER 10, 2018

Founded 2006. Founded 2006. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. 251-500 employees.

Sales 76

Sales Management Marketing Education 76

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. BIIB107 is a monoclonal antibody that targets ?4

Government 59

Government Specialization Physicians Marketing 59

European Pharmaceutical Review

DECEMBER 19, 2022

European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006″ European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006. The Impact of Biosimilar Competition in Europe, IQVIA, December 2021.

Medicine 52

Medicine Biopharma Safety Food 52

Pharmaceutical Technology

JULY 10, 2008

The past Global figures from PwC show that in 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old. “In 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old.”

Food and Drug Administration 40

Food and Drug Administration Medicine Pharmaceutical Medical 40

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Medical 117

Medical Government Marketing Medicine 117

Evolve Your Success

JANUARY 23, 2024

In 2006 or even a little bit earlier than that, Joel Matta was a very well-known orthopedic surgeon. Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The Caribbean’s got a little difficult to navigate in. Walk us through the process. How did OrthoGrid spawn? What happened?

Medical sales 130

Medical sales Sales Medical Physicians 130

World of DTC Marketing

JANUARY 31, 2021

2wo: The number of mergers and acquisitions(M&A) involving one of the top 25 firms in the pharmaceutical industry more than doubled from 2006 to 2016, and the practice doesn’t seem to be abating. So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). By the way, Ms.

Pharma 187

Pharma Insurance Pharmaceutical Healthcare 187

Pharmaceutical Technology

JULY 23, 2008

“There’s a huge clinical need which has been undelivered for years,” says Gustav Ando, manager of the healthcare business development unit [HBDU] at Global Insight. All those people need treatment, which creates demand for drugs and stimulates growth in the sector. There’s been a huge change in the market.”

Side effects 40

Side effects Marketing Pharmaceutical Sales 40